Pepcid Complete is a Oral Tablet, Chewable in the Human Otc Drug category. It is labeled and distributed by Select Corporation. The primary component is Calcium Carbonate; Famotidine; Magnesium Hydroxide.
| Product ID | 52904-948_fba25037-8f64-4e0d-b2bd-cc1f307c01c6 |
| NDC | 52904-948 |
| Product Type | Human Otc Drug |
| Proprietary Name | Pepcid Complete |
| Generic Name | Famotidine, Calcium Carbonate, And Magnesium Hydroxide |
| Dosage Form | Tablet, Chewable |
| Route of Administration | ORAL |
| Marketing Start Date | 2009-01-01 |
| Marketing Category | NDA / |
| Application Number | NDA020958 |
| Labeler Name | Select Corporation |
| Substance Name | CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE |
| Active Ingredient Strength | 800 mg/1; mg/1; mg/1 |
| Pharm Classes | Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2009-01-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 16837-246 | Pepcid Complete | Famotidine, Calcium Carbonate, and Magnesium Hydroxide |
| 16837-298 | Pepcid Complete | Famotidine, Calcium carbonate, and Magnesium hydroxide |
| 16837-891 | Pepcid Complete | famotidine, calcium carbonate, and magnesium hydroxide |
| 50269-016 | Pepcid Complete | FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE |
| 52904-948 | Pepcid Complete | Famotidine, Calcium Carbonate, and Magnesium Hydroxide |
| 66715-9822 | Pepcid Complete | Famotidine, Calcium Carbonate, Magnesium Hydroxide Chewable Tablet |
| 67751-202 | Pepcid Complete | Famotidine, Calcium carbonate, and Magnesium hydroxide |
| 70264-034 | Pepcid Complete | famotidine, calcium carbonate, and magnesium hydroxide |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() PEPCID COMPLETE 86459772 4772806 Live/Registered |
JOHNSON & JOHNSON 2014-11-20 |
![]() PEPCID COMPLETE 76165191 2629164 Dead/Cancelled |
JOHNSON & JOHNSON 2000-11-15 |